As of 2024-07-27, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (36.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -82225.7%.
The range of the Relative Valuation is (38.82) - (37.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 23.8x - 30.1x | 27.0x |
| Fair Price | (38.82) - (37.94) | (36.71) |
| Upside | -86948.8% - -84974.9% | -82225.7% |
| Date | P/E |